A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss

Clinical trial NCT07663630 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07663630
Sponsor: Pfizer
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)Cachexia

Start date: 2026-07-22
Primary completion: 2028-02-02
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.